Your session is about to expire
← Back to Search
Behavioral Intervention
Gait Therapy for Cerebral Palsy
N/A
Recruiting
Led By Max J Kurz, PhD
Research Sponsored by Father Flanagan's Boys' Home
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Cerebral Palsy diagnosis for Cerebral Palsy participants
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (cp) and 8 weeks (cp)
Awards & highlights
No Placebo-Only Group
Summary
This trial will study the effects of a therapeutic gait training protocol on adolescents and young adults with cerebral palsy. Blah blah metal in their body will interfere with MRI so they can't do that part of the study. A control group of neurotypical adolescents and young adults will also be assessed.
Who is the study for?
This trial is for adolescents and young adults with cerebral palsy who haven't had orthopedic surgery in the last 6 months and don't have metal implants that would affect MRI scans. Neurotypical individuals without conditions like autism or ADHD can participate as controls.
What is being tested?
The study tests a gait training protocol to improve walking in those with cerebral palsy. It includes brain imaging, neurophysiological tests, mobility assessments, and cognitive tests before and after the therapy.
What are the potential side effects?
While not explicitly stated, potential side effects may include muscle fatigue, discomfort during exercise, or soreness from gait therapy. Brain imaging is non-invasive but may be uncomfortable due to stillness required.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Cerebral Palsy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (cp) and 8 weeks (cp)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (cp) and 8 weeks (cp)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Brain Activity in Sensory Cortices
Change in Hoffmann Reflex
Change in Isolation of Movement
+6 moreSecondary study objectives
Cognitive related changes induced via physical therapy - Caregiver Priorities & Child Health Index of Life with Disabilities (CPCHILD) Questionnaire
Cognitive related changes induced via physical therapy - Child and Adolescent Sleep Checklist (CASC)
Cognitive related changes induced via physical therapy - D2 - Test of Attention
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cerebral Palsy Youth/Young AdultsExperimental Treatment1 Intervention
Baseline and 8 week assessments; 8 week gait therapy
Group II: Neurotypical Youth/Young AdultsActive Control1 Intervention
No intervention administered. The controls will only undergo initial baseline assessments.
Find a Location
Who is running the clinical trial?
Father Flanagan's Boys' HomeLead Sponsor
12 Previous Clinical Trials
1,458 Total Patients Enrolled
2 Trials studying Cerebral Palsy
114 Patients Enrolled for Cerebral Palsy
Max J Kurz, PhDPrincipal InvestigatorFather Flanagan's Boys' Home
4 Previous Clinical Trials
185 Total Patients Enrolled
3 Trials studying Cerebral Palsy
153 Patients Enrolled for Cerebral Palsy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't had any bone surgery in the past 6 months.You do not have any metal in your body that would prevent you from having an MRI.I have been diagnosed with Cerebral Palsy.You do not have conditions like autism, Down Syndrome, or ADHD for the control group without cerebral palsy.
Research Study Groups:
This trial has the following groups:- Group 1: Cerebral Palsy Youth/Young Adults
- Group 2: Neurotypical Youth/Young Adults
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.